SLS
Sellas Life Sciences Group Inc
NASDAQ: SLS · HEALTHCARE · BIOTECHNOLOGY
$4.95
+6.00% today
Updated 2026-04-30
Market cap
$900.52M
P/E ratio
—
P/S ratio
26.90x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$1 – $6
Volume
6.7M
WallStSmart proprietary scores
17
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$10.00
+102.02%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.92M
- Revenue declining -82.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-41.30M | $-37.34M | $-30.88M | $-26.86M | $-7.66M |
| EPS | — | — | — | — | $-0.25 |
| Free cash flow | $-28.31M | $-36.91M | $-35.40M | $-28.39M | $-4.92M |
| Profit margin | -4,130.10% | — | — | — | — |
Peer comparison
Smart narrative
Sellas Life Sciences Group Inc trades at $4.95. Our Smart Value Score of 17/100 indicates the stock is weak.
Frequently asked questions
What is Sellas Life Sciences Group Inc's stock price?
Sellas Life Sciences Group Inc (SLS) trades at $4.95.
Is Sellas Life Sciences Group Inc overvalued?
Smart Value Score 17/100 (Grade F, Strong Sell).
What is the price target of Sellas Life Sciences Group Inc (SLS)?
The analyst target price is $10.00, representing +102.0% upside from the current price of $4.95.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio26.90x
ROE-66.90%
Beta2.23
50D MA$4.83
200D MA$2.91
Shares out0.18B
Float0.18B
Short ratio—
Avg volume6.7M
Performance
1 week+0.65%
1 month+10.40%
3 months+20.05%
YTD+23.87%
1 year—
3 years—
5 years—